ZNO Zoono Group Limited
Consumer Defensive · Household & Personal Products
· website
$0.05
52wk 0.03 – 0.17
Overall
28.2
Value
52.6
Growth
0.0
Health
69.2
Quality
0.0
Momentum
7.0
Dividend
—
Price
About Zoono Group Limited
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand, Australasia, Asia, the United States, India, the United Kingdom, and Europe. It offers hand and surface sanitisers, textile applicator, and mould remediation products. Zoono Group Limited was founded in 2007 and is headquartered in Auckland, New Zealand.
Price analytics
Returns
| 1 day | -5.9% |
| 1 week | -7.7% |
| 1 month | 2.1% |
| 3 months | -14.3% |
| 6 months | -20.0% |
| 1 year | 39.1% |
| 3 years | 37.1% |
Risk
| Volatility (1y ann.) | 135.8% |
| Beta vs ASX 200 | 0.76 |
| Sharpe (1y) | 0.84 |
| VaR 95% (1-day) | -9.1% |
| Max drawdown (1y) | -69.7% |
| Off 1-year high | -69.0% |
Technicals
| RSI(14) | 38 |
| vs 50DMA | -5.5% |
| vs 200DMA | -21.7% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
52.6
Trailing P/E
—
Forward P/E
—
PEG ratio
49
EV / EBITDA
100
Price / Book
31
Price / Sales
0
Growth
0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
69.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow)
0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
7.0
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
23
Position in 52-week range
11
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$19.50M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
1.21
EV / EBITDA
-14.26
Price / Book
5.76
ROE
-54.6%
Operating margin
-31.8%
Net margin
-107.0%
Total cash
$268,120
Total debt
$363,586
Current ratio
4.78
Debt / Equity
0.10
Free cash flow
$-872,734
Avg volume
37,228
Latest annual results
(FY ending 30 Jun 2024)
- Revenue$960.30K
- Gross profit$251.07K
- Operating income-$3.72M
- Net income-$8.32M
- Diluted EPS-0.04
- Free cash flow-$2.89M
- Net debt-$1.07M